Rasmus Michael Sandsdal

Rasmus Michael Sandsdal serves as an MD PhD fellow in the Department of Biomedical Sciences at the University of Copenhagen's Faculty of Health and Medical Sciences, working within the Torekov Group. His research focuses on obesity, metabolic disorders, and clinical interventions.

Dr. Sandsdal's research interests primarily center around obesity treatment mechanisms, weight loss maintenance strategies, and metabolic health outcomes. His work examines the physiological effects of various interventions including exercise, GLP-1 receptor agonists like semaglutide, and combination therapies on metabolic syndrome, bone health, vitamin D status, and other biomarkers. His studies often employ rigorous clinical trial methodologies to assess both short-term and long-term effects of weight loss interventions.

His publication record demonstrates significant impact, with several papers receiving substantial attention across academic and clinical communities. His 2023-2025 publications have been picked up by numerous news outlets, referenced on social media platforms, and cited in clinical guidelines, reflecting the relevance of his work to current medical practice.

Dr. Sandsdal also maintains a clinical role as a Consultant MD at Copenhagen University Hospital - Amager and Hvidovre since 2024, bridging his research with clinical practice. His collaborative work within the Torekov Group demonstrates extensive networking across multiple institutions and research disciplines related to metabolic health.